Seeking Alpha

PPHMstockofcentury

PPHMstockofcentury
Send Message
View as an RSS Feed
View PPHMstockofcentury's Comments BY TICKER:
Latest  |  Highest rated
  • Peregrine Pharmaceuticals' Bavituximab: It's Time To Throw In The Towel [View article]
    Robert Schwartz,

    I find it unprofessional that you would surmise that Peregrine management lacks confidence in the drug (Bavituximab) or would simply continue trials to collect their salaries? Would you want to respond differently at this point, since Peregrine has gained recognition from many of the worlds top "cancer immunotherapy" specialists... including: Dimitry Gabrilovich (Translational Tumor Immunology
    The Wistar Institute, Philadelphia, Pennsylvania), Dr. Scott Antonia (H. Lee Moffitt Cancer Center), Dr. David Carbone (Ohio State University- Comprehensive Cancer Center)..and HÃ¥kan Mellstedt (Karolinska University Hospital, Stockholm, Sweden)-- all of which have joined the Medical/Scientific Advisory board of Peregrine on Dec 10, 2014.

    Peregrine has some interesting Bavituximab combination data this week.... in combination anti-PD1 and anti-PD-L1 that I'm sure will change your mind.

    -Jack
    Jan 25, 2014. 07:14 PM | Likes Like |Link to Comment
  • Peregrine Pharmaceuticals' Bavituximab: It's Time To Throw In The Towel [View article]
    Thanks for answering my previous questions Mr. Swartz. I do have to say, I'm very grateful that I don't listen to many of the articles that were published regarding Peregrine Pharmaceuticals. The FDA, announcing Fast Track designation for immunotherapy Bavituximab in NSCLC seems to have threw the towel in for the reasoning your based this article on it seems.

    Do you still agree with the title of your article and that Peregrine should throw in the towel? If you do, it would remind me of myself when I was 16 and thought I knew it all.
    Jan 7, 2014. 08:29 AM | Likes Like |Link to Comment
  • Bristol-Myers Squibb Vs. Roche In The Brain Cancer Race [View article]
    Peter, thanks for shining some light on GBM... certainly a high-unmet need and additional treatment is needed.

    It seems that much of the immuno-therapy talk as of late is missing a critical requirement that is needed to improve overall response rates... and that is the targeting of "Phosphatidylserine" which globally targets the entire spectrum that all others such as PD-1, PD-L1, ITL-2, CTLA-4..etc which only target a small portion of this spectrum and is representative on all solid tumors, GBM, Lung Cancer, Breast Cancer, Melanoma..etc ..etc

    The Key Opinion Leaders and MOA of Bavituximab is explained in detail below... and is a "requirement" for immunotherapy to achieve a maximum immune response.

    http://bit.ly/19N9tkb
    Jan 2, 2014. 12:45 PM | 1 Like Like |Link to Comment
  • Peregrine: Bavi Results Are Overhyped And Inconclusive [View article]
    Great Response! All Heart in there and agree with everything you've said. I am looking forward to the day when Peregrine Pharmaceuticals can finally advance Bavituximab and allow patients the choice of a lifetime in cancer treatment.
    Dec 31, 2013. 01:18 AM | Likes Like |Link to Comment
  • Has Peregrine Pharmaceuticals Finally Turned The Corner? [View article]
    Bio Matt, would you like to go on record if you have purchased any Peregrine Pharmaceutical stock since your article? Time is ticking and once it hits $5 I'm sure we will see some more articles telling people to take profits : ) I'll be waiting for triple digits
    Oct 14, 2013. 12:43 AM | Likes Like |Link to Comment
  • Peregrine Pharmaceuticals' Bavituximab: It's Time To Throw In The Towel [View article]
    Dr. Schwartz, would you like to go on record and give your opinion of Peregrine receiving any BTD from the FDA? and their upcoming meetings taking place in Sydney, Australia concerning immunotherapy and combination synergies with their PS targeting, patented drugs?

    Are you still surprised they haven't thrown in the towel ?
    Oct 13, 2013. 03:59 PM | Likes Like |Link to Comment
  • Has Peregrine Pharmaceuticals Finally Turned The Corner? [View article]
    Biomatt, thanks for the article. You made a major mistake though in suggesting there is a problem because there is no partner at this time.
    I suggest you research Bavituximab and beta bodies. It will play a big part in changing the oncology landscape.
    Jun 15, 2013. 08:00 PM | Likes Like |Link to Comment
  • Has Peregrine Pharmaceuticals Finally Turned The Corner? [View article]
    biojedi, you are completely wrong. Chewbacca would not even follow you down this jedi path. Bavituximab is the future of many FDA approvals.

    The FDA just approved a Phase III NSCLC Bavi trial.
    Jun 15, 2013. 07:53 PM | Likes Like |Link to Comment
  • Peregrine Pharmaceuticals' Bavituximab: It's Time To Throw In The Towel [View article]
    Dr. Schwartz:

    You stated: A large well powered study would have gotten them an SPA....

    but the FDA doesn't even require large well powered studies to be given Breakthrough Designation. If the drug shows safety and effectiveness... which Bavi shows for multiple solid tumors... it will be granted. I do think ASCO 2013 will be an eye opener for the Bavi pipeline.
    May 29, 2013. 08:42 PM | Likes Like |Link to Comment
  • Peregrine Pharmaceuticals' Bavituximab: It's Time To Throw In The Towel [View article]
    Dr. Robert Schwartz,

    I have a couple questions regarding this article:

    1) Do you have any affiliations with an oncology space Big Pharma that would have any of their drugs be placed in direct competition with the approval of Bavituximab in lung, breast, pancreatic, or liver cancer? When I say affiliations it could be ex-employer or any of your clients in the past/present from RHS advisors ?

    2) Have you ever in the past or present owned any shares or known any of your clients from RHS advisors or ex-employers to hold any shares in Peregrine Pharmaceuticals?

    Thanks...
    May 24, 2013. 10:20 PM | Likes Like |Link to Comment
  • Peregrine Pharmaceuticals, The Little Biotech With The Golden Goose Of Immunotherapy [View article]
    Agree! Now ASCO is perfect timing for a follow up on an article like that. It makes me wish I continued as a research scientist after dissecting that frog in the 9th grade! : )

    I think its time for Peregrine to start dissecting some of the major BP's in the oncology space-- which one will they hopefully partner with is the question!
    May 24, 2013. 10:27 AM | Likes Like |Link to Comment
  • Peregrine Pharmaceuticals, The Little Biotech With The Golden Goose Of Immunotherapy [View article]
    a lot of courage.. yes : ) but something tells me that Seeking Alpha may not have "allowed" this type of article just a few months back.

    If they really would have... well then there are not many that know much of the potential of Bavituximab. The IHUB board has some good information on Peregrine in case you are interested!

    PPHM Stock Of The Century

    http://bit.ly/11igkyV
    May 24, 2013. 10:17 AM | Likes Like |Link to Comment
  • Peregrine Pharmaceuticals, The Little Biotech With The Golden Goose Of Immunotherapy [View article]
    I have to respectfully disagree there.... The FDA has been lobbied by Big Pharma for many years and with this last year of events-- they have been placed on warning. Giving the Bavituximab Phase IIb NSCLC trial the go ahead to Phase III ( which looks like its 600 patients... with a peak at 150 so could be stopped at 150) would "NEVER" be given to any pharma if they didn't have any vote of confidence.

    Actually... The FDA giving Peregrine Pharmaceuticals the go ahead for Phase III ... is one "major" sign that they (The FDA) are backing off of Big Pharma lobbyists.... because they have been against Peregrine for quite some time now

    Its only a matter of time now... its been known for a while that Bavi could replace... or "most definately" work with many Big Pharma current SOC drugs... so I see one of them stepping up and partnering with Peregrine.
    May 23, 2013. 09:03 PM | 8 Likes Like |Link to Comment
  • Peregrine Pharmaceuticals, The Little Biotech With The Golden Goose Of Immunotherapy [View article]
    jq1234... not sure if you understand the science behind Bavituximab. Dr. Philip Thorpe was the inventor ... (he passed away back in April unfortunately) but if you google his name .. and UTSWM - University of Texas Southwestern Medical you'll find some good info! He was a pure genius. A student of his.. Dr. Rolf Brekken was involved and on many patents with him as well... actually Dr. Brekken has a lab at UTSWM as well... most likely he will be taking over for Dr. Thorpe.
    May 23, 2013. 08:56 PM | 10 Likes Like |Link to Comment
  • Peregrine Pharmaceuticals, The Little Biotech With The Golden Goose Of Immunotherapy [View article]
    what prize?
    May 23, 2013. 08:51 PM | Likes Like |Link to Comment
COMMENTS STATS
26 Comments
35 Likes